Today's Daily Dose brings you news about Aytu BioScience's progress in its COVID-19 diagnostic tests, Roche's myeloid leukemia trial results, Milestone Pharma's disappointing NODE-301 trial results and Hoth Therapeutics getting on the bandwagon of COVID-19 drug development.
from RTT - Biotech https://ift.tt/3aglWzZ
via IFTTT
No comments:
Post a Comment